SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-038465
Filing Date
2021-02-11
Accepted
2021-02-11 16:15:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d116545dsc13ga.htm SC 13G/A 41289
  Complete submission text file 0001193125-21-038465.txt   42607
Mailing Address C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Socks David A (Filed by) CIK: 0001378847 (see all company filings)

Type: SC 13G/A

Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Subject) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91182 | Film No.: 21619863
SIC: 2834 Pharmaceutical Preparations